Avendus Capital

Avendus Capital is a prominent financial advisory firm based in Mumbai, India, established in 1999. The firm specializes in investment banking, asset management, credit solutions, and wealth management services. Avendus Capital caters to a diverse clientele, including mid-market companies and large multinational organizations, offering tailored solutions from growth-stage funding to complex transactions. The firm operates across six specialized verticals: Digital & Technology, Consumer and Financial Services, Healthcare, Enterprise Technology & Services, Infrastructure & Real Assets, and Industrials. With a strong emphasis on entrepreneurship, Avendus Capital provides comprehensive advisory services in mergers and acquisitions, along with strategic insights for companies and private equity funds, leveraging its extensive experience and deep domain expertise.

Anshul Agarwal

Managing Director and Co-head, Consumer, FIG and Business Services

Apurva Sahijwani

Managing Director and CEO

Past deals in Series I

Lenskart

Series I in 2022
Lenskart Solutions Private Limited operates as a prominent online eyewear retailer in India, offering a wide range of products including prescription glasses, sunglasses, and contact lenses for men, women, and children. Established in 2008 and based in New Delhi, the company has expanded its presence through numerous retail stores across various cities in India. Lenskart is known for its user-friendly online platform, where customers can select from over 500 designs of eye frames and enjoy features like 48-hour free home delivery and a 365-day return policy. The company provides an extensive selection of contact lenses from leading brands, catering to diverse customer needs. Additionally, Lenskart offers home eye check-up services in several major cities, enhancing customer convenience and accessibility to eye care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.